Compare Kosmos Energy Ltd. Common Shares (DE) (KOS) vs Vaxcyte Inc. Common Stock (PCVX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Kosmos Energy Ltd. Common Shares (DE) vs Vaxcyte Inc. Common Stock — how do they compare? Kosmos Energy Ltd. Common Shares (DE) trades at $2.71 (market cap $1.66B), while Vaxcyte Inc. Common Stock trades at $67.37 (market cap $10.51B). The key difference: Vaxcyte Inc. Common Stock is far larger — about 6.3× Kosmos Energy Ltd. Common Shares (DE)'s market cap, and Kosmos Energy Ltd. Common Shares (DE) is more actively traded (7,535,344 versus 2,644,694). Which is the better fit depends on your goals — on Pluang, investors hold Kosmos Energy Ltd. Common Shares (DE) for 0 Days and Vaxcyte Inc. Common Stock for 0 Days on average.
| KOS | PCVX | |
|---|---|---|
Market Cap | $1.66B | $10.51B |
Volume | 7,535,344 | 2,644,694 |
Sector | Energy | Health |
52-Week High | $3.27 | $73.82 |
52-Week Low | $0.87 | $40.32 |
Typical Hold Time | 0 Days | 0 Days |
Enterprise Value | $4.30B | $9.14B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Kosmos Energy Ltd. Common Shares (DE)
Kosmos Energy Ltd. is a deepwater oil and gas exploration and production company with operations offshore Ghana, Equatorial Guinea, Mauritania, and Senegal in West Africa.
Read more on KOS →About Vaxcyte Inc. Common Stock
Vaxcyte, Inc. is a clinical-stage vaccine company that engineers protein-based vaccines to prevent bacterial diseases such as invasive pneumococcal disease, using its proprietary cell-free protein synthesis platform to develop candidates including the pneumococcal conjugate vaccines VAX-31 and VAX-24.
Read more on PCVX →
